Sangamo Therapeutics Inc. buy Truist Financial Co.
Start price
13.12.24
/
50%
€2.04
Target price
13.12.25
€6.66
Performance (%)
-81.30%
End price
14.12.25
€0.38
Summary
This prediction ended on 14.12.25 with a price of €0.38. The BUY prediction by Truist_Financial_Co_ for Sangamo Therapeutics Inc. performed very badly with a performance of -81.30%. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Sangamo Therapeutics Inc. | 0.000% | 0.000% | -70.551% |
| iShares Core DAX® | 1.001% | -1.218% | 13.263% |
| iShares Nasdaq 100 | -1.447% | -4.597% | 0.414% |
| iShares Nikkei 225® | 8.406% | 8.425% | 27.328% |
| iShares S&P 500 | -0.226% | -2.451% | 0.167% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Sangamo Bioscienes diskutieren
Sangamo Therapeutics, Inc. (NASDAQ: SGMO) was upgraded by analysts at Truist Financial Co. from a "hold" rating to a "buy" rating. They now have a $7.00 price target on the stock.
Ratings data for SGMO provided by MarketBeat
In the thread Trading Sangamo Bioscienes
Die von Truist_Financial_Co_ gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Truist_Financial_Co_ for Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.12
23.01.25
23.01.25
€4.80
23.01.26
23.01.26
-71.24%
24.01.26
24.01.26
Sangamo Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.93
15.08.23
15.08.23
€6.40
15.08.24
15.08.24
-13.17%
16.08.24
16.08.24